Ετικέτες

Δευτέρα 22 Ιανουαρίου 2018

Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study).

Author: Mahaffey, Kenneth W. MD; Neal, Bruce MB, ChB, PhD; Perkovic, Vlado MBBS, PhD; de Zeeuw, Dick MD, PhD; Fulcher, Greg MD; Erondu, Ngozi MD, PhD; Shaw, Wayne DSL; Fabbrini, Elisa MD, PhD; Sun, Tao PhD; Li, Qiang MBiostat, BPH, AStat; Desai, Mehul MD; Matthews, David R. DPhil, BM, BCh; On behalf of the CANVAS Program Collaborative Group
Page: 323-334


http://ift.tt/2Bl7Bjx

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αναζήτηση αυτού του ιστολογίου